Description: This discussion at the SOA 2000 Las Vegas Spring Meeting focuses on the polictical landscape with respect to health care issues including Medicare, prescription drug coverage, the concept of a patient's 'bill of rights', and other health care reform ideas.

Description: Long-Term Care News

Description: Presented at October 1996 Annual Meeting. In this discussion, panelists look at nontraditional disability delivery approaches - such as direct marketing, banks and internet - and competitors for insurance companies in disability management - such as HMOs and management consulting firms.

Description: 1993 SOA Spring Meeting, Boston. This session discussion is about new dimensions of pricing and risk selection for direct-response insurance products. Topics discussed: 1. Multiple dimensional set of assumptions relating response rates. 2. Expected claims. 3. Projected persistency. 4. Customer buying propensities.

Description: An examination of past Flaspohler Survey data to identify drivers of direct writer satisfaction with reinsurers.

Description: Panelists discuss the various managed-care alternatives as well as ways to evaluate their effectiveness. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.

Description: This session discussion is about the effect of changes in medical practices and technology, effect of cost shifting, measurement and analysis and employers' perspective. From Record of the Society of Actuaries Vol. 15, No. 3A.

Description: This session will address the increased cases of managed care in Medicaid states. This will include some indication of how utilization patterns differ for those populations versus commercial populations. From the Record of the Society of Actuaries, Vol. 21, No. 3b.

Description: An update on HMO market trends and reinsurance products, and services supporting them.

Description: Answers to questions that have surfaced with regard to recent trends in the use of psychiatric medications, including relative effectiveness compared to prescribing patterns, drivers of prescribing patterns, classification and indications for recently publicized drugs, role of primary care providers, preventive use ofdementia medications, and new developments in the field.